Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
DNA damage produces delayed mitosis (G2/M delay) in proliferating cells, and shortening the delay sensitizes human malignant glioma and medulloblastoma cells to cytotoxic chemotherapy. Although activation of the cyclin-dependent kinase CDC2 mediates G2/M transition in all tumor cells studied to date...
Main Authors: | Janss, A, Maity, A, Tang, C, Muschel, R, Mckenna, W, Sutton, L, Phillips, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Camptothecin Effectively Regulates Germline Differentiation through Bam–Cyclin A Axis in <i>Drosophila melanogaster</i>
by: Jing Zhang, et al.
Published: (2023-01-01) -
Total synthesis of ḏḻ-camptothecin.
by: Bradley, Joel Chandler.
Published: (2022) -
Injectable Hydrogel System for Camptothecin Initiated Nanocatalytic Tumor Therapy With High Performance
by: Shuntao Wang, et al.
Published: (2022-06-01) -
Camptothecin-based nanodrug delivery systems
by: Yan Wen, et al.
Published: (2017-08-01) -
Zingerone Suppresses Tumor Development through Decreasing Cyclin D1 Expression and Inducing Mitotic Arrest
by: Jae-Sun Choi, et al.
Published: (2018-09-01)